Related Experiment Video
Updated: Jul 4, 2025

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
Ku70 senses cytosolic DNA and assembles a tumor-suppressive signalosome
Abhimanu Pandey1, Cheng Shen1, Shouya Feng1
1Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia.
Abstract:
The innate immune response contributes to the development or attenuation of acute and chronic diseases, including cancer. Microbial DNA and mislocalized DNA from damaged host cells can activate different host responses that shape disease outcomes. Here, we show that mice and humans lacking a single allele of the DNA repair protein Ku70 had increased susceptibility to the development of intestinal cancer. Mechanistically, Ku70 translocates from the nucleus into the cytoplasm where it binds to cytosolic DNA and interacts with the GTPase Ras and the kinase Raf, forming a tripartite protein complex and docking at Rab5+Rab7+ early-late endosomes. This Ku70-Ras-Raf signalosome activates the MEK-ERK pathways, leading to impaired activation of cell cycle proteins Cdc25A and CDK1, reducing cell proliferation and tumorigenesis. We also identified the domains of Ku70, Ras, and Raf involved in activating the Ku70 signaling pathway. Therapeutics targeting components of the Ku70 signalosome could improve the treatment outcomes in cancer.
Insights
A DNA repair protein, Ku70, normally prevents intestinal cancer by forming a signalosome that reduces cell proliferation. Loss of one Ku70 gene copy increases cancer risk.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- The innate immune system plays a role in disease development, including cancer.
- Host responses to microbial or host DNA influence disease progression.
- DNA damage and repair mechanisms are critical in cancer etiology.
Purpose of the Study:
- To investigate the role of the DNA repair protein Ku70 in intestinal cancer development.
- To elucidate the molecular mechanisms by which Ku70 influences tumorigenesis.
- To identify potential therapeutic targets within the Ku70 signaling pathway.
Main Methods:
- Analysis of mice and humans with altered Ku70 gene dosage.
- Cellular localization studies of Ku70.
- Protein-protein interaction assays to identify components of the Ku70 signalosome.
- Western blotting and cell cycle analysis to assess pathway activation.
Main Results:
- Reduced Ku70 levels increase susceptibility to intestinal cancer.
- Ku70 translocates to the cytoplasm, binds cytosolic DNA, and forms a complex with Ras and Raf.
- This Ku70-Ras-Raf signalosome activates MEK-ERK pathways, inhibiting cell cycle proteins Cdc25A and CDK1.
- Inhibition of cell cycle progression by Ku70 reduces cell proliferation and tumorigenesis.
Conclusions:
- Ku70 acts as a tumor suppressor in the intestine by regulating cytosolic DNA-mediated signaling.
- The Ku70-Ras-Raf signalosome is a key regulator of cell proliferation and cancer development.
- Targeting components of the Ku70 signalosome may offer novel therapeutic strategies for cancer treatment.
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
DNA Damage can Stall the Cell Cycle

